← Open Payments lookup

SABRINA BOLIANITES: Open Payments

NPI 1043790413 · CONCORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$912 in 14 payments from 10 companies in 2025. Trend: 2023 $608 · 2024 $911 · 2025 $912

Food & beverage: $912
CompanyPaymentsAmount
Daiichi Sankyo Inc.2$156
Blueprint Medicines Corporation2$145
SERVIER PHARMACEUTICALS LLC1$124
Gilead Sciences, Inc.1$109
Amgen Inc.1$100
E.R. Squibb & Sons, L.L.C.1$95
Takeda Pharmaceuticals U.S.A., Inc.3$74
Novartis Pharmaceuticals Corporation1$64
AstraZeneca Pharmaceuticals LP1$26
Genentech USA, Inc.1$19

Products named: Trodelvy, IMDELLTRA (AMG757), Enhertu, REBLOZYL, NINLARO, SCEMBLIX, DATROWAY, TAGRISSO.

Industry payments across NH — which companies pay providers there.